BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20402671)

  • 1. Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.
    Wang JP; Zhang Y; Wei X; Li J; Nan XP; Yu HT; Li Y; Wang PZ; Bai XF
    APMIS; 2010 Apr; 118(4):261-70. PubMed ID: 20402671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection.
    Zhang Y; Lian JQ; Huang CX; Wang JP; Wei X; Nan XP; Yu HT; Jiang LL; Wang XQ; Zhuang Y; Li XH; Li Y; Wang PZ; Robek MD; Bai XF
    Virology; 2010 Feb; 397(1):34-42. PubMed ID: 19945134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury.
    Riordan SM; Skinner NA; Kurtovic J; Locarnini S; McIver CJ; Williams R; Visvanathan K
    Inflamm Res; 2006 Jul; 55(7):279-85. PubMed ID: 16955390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of innate immunity in the pathogenesis of chronic hepatitis C in children.
    Wisniewska-Ligier M; Wozniakowska-Gesicka T; Glowacka E; Lewkowicz P; Banasik M; Tchorzewski H
    Scand J Immunol; 2006 Oct; 64(4):425-32. PubMed ID: 16970685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2.
    Chung H; Watanabe T; Kudo M; Chiba T
    J Infect Dis; 2010 Sep; 202(6):853-61. PubMed ID: 20677943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Toll-like receptors in chronic hepatitis C virus infection.
    Sato K; Ishikawa T; Okumura A; Yamauchi T; Sato S; Ayada M; Matsumoto E; Hotta N; Oohashi T; Fukuzawa Y; Kakumu S
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1627-32. PubMed ID: 17845690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
    Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
    Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
    Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
    Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection.
    Shehata MA; Abou El-Enein A; El-Sharnouby GA
    Egypt J Immunol; 2006; 13(1):141-52. PubMed ID: 17974158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of Toll-like receptor (TLR) 2 and TLR4 on the peripheral blood mononuclear cells in patients with chronic hepatitis B and chronic severe hepatitis B].
    Wei XQ; Wen ZF; Zheng FP; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):354-7. PubMed ID: 17524268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of T-regulatory cells and Toll-like receptors 2 and 4 in atopic dermatitis.
    Lesiak A; Smolewski P; Sobolewska-Sztychny D; Sysa-Jedrzejowska A; Narbutt J
    Scand J Immunol; 2012 Oct; 76(4):405-10. PubMed ID: 22686584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients.
    Chen Z; Cheng Y; Xu Y; Liao J; Zhang X; Hu Y; Zhang Q; Wang J; Zhang Z; Shen F; Yuan Z
    Clin Immunol; 2008 Sep; 128(3):400-8. PubMed ID: 18565796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?
    Godkin A; Ng WF; Gallagher K; Betts G; Thomas HC; Lechler RI
    J Allergy Clin Immunol; 2008 May; 121(5):1277-1284.e3. PubMed ID: 18355912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TLR2 and TLR4 in human neutrophil functions against Paracoccidioides brasiliensis.
    Acorci-Valério MJ; Bordon-Graciani AP; Dias-Melicio LA; de Assis Golim M; Nakaira-Takahagi E; de Campos Soares AM
    Scand J Immunol; 2010 Feb; 71(2):99-108. PubMed ID: 20384861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of toll-like receptors 2 and 4 is upregulated during hospital admission in traumatic patients: lack of correlation with blunted innate immune responses.
    Pérez-Bárcena J; Regueiro V; Crespí C; Pierola J; Oliver A; Llompart-Pou JA; Ayestarán JI; Raurich JM; Marsé P; Ibáñez J; Bengoechea JA
    Ann Surg; 2010 Mar; 251(3):521-7. PubMed ID: 20134316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid.
    Zhang Q; Qian FH; Liu H; Zhou LF; Huang M; Zhang XL; Yin KS
    Chin Med J (Engl); 2008 Feb; 121(3):205-12. PubMed ID: 18298910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased CD4
    Wei K; Jiang BC; Guan JH; Zhang DN; Zhang MX; Wu JL; Zhu GZ
    Viral Immunol; 2018 Oct; 31(8):559-567. PubMed ID: 30067145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
    Arranz A; Juarranz Y; Leceta J; Gomariz RP; Martínez C
    Peptides; 2008 Jun; 29(6):948-56. PubMed ID: 18359536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte toll-like receptor expression in end-stage kidney disease.
    Gollapudi P; Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
    Am J Nephrol; 2010; 31(3):247-54. PubMed ID: 20090311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.